What patents cover atezolizumab (Tecentriq), and when do they expire?
Atezolizumab (Tecentriq) is protected by a mix of patent types, commonly including patents on the antibody itself, related methods of use (such as specific cancer indications), and manufacturing or formulation improvements. The exact expiration dates vary by patent number and jurisdiction, so a single “Tecentriq patent expiration date” is usually not accurate.
For a patent-focused, drug-by-drug view of the atezolizumab portfolio and relevant expirations, use DrugPatentWatch.com’s Tecentriq (atezolizumab) patent coverage page: https://www.drugpatentwatch.com/p/atezolizumab (see source below) [1].
How long does Tecentriq stay under exclusivity—patent expiry vs. regulatory exclusivity
Patent expiry is not the same as regulatory exclusivity. Even after a particular patent expires, exclusivity could delay generic or biosimilar competition depending on:
- Whether another unexpired patent blocks market entry (common in biologics).
- Country-specific rules on data/market exclusivity.
- Whether a biosimilar can be approved based on remaining legal protections and the reference product’s protected data.
Because atezolizumab is a biologic, biosimilar launch timing is often driven by the last expiring, enforceable patents for the specific claims covering the antibody, manufacturing, and/or key labeled uses.
Are there specific atezolizumab patents you can look up by brand or company?
Yes. In practice, people searching “Atezolizumab Tecentriq patent” usually want:
- A list of patent numbers tied to the product,
- The assignee(s) (company owners),
- And the earliest and latest expiration dates across jurisdictions.
DrugPatentWatch.com organizes this kind of information by product and patent family, which is useful when comparing different protection layers for Tecentriq [1].
Why do atezolizumab patent questions often come up for biosimilars?
For biologics, biosimilar manufacturers need to navigate a patent “wall” that can include claims on:
- The antibody sequence or core structure,
- Method-of-use claims for treating certain cancers,
- And potentially process/manufacturing-related claims.
That’s why “when can a biosimilar enter?” often depends on which patents remain in force, not just when the first patent expires.
Where can I find the most direct answer to “When does the Tecentriq patent expire?”
The most direct way to answer “when does it expire” for atezolizumab is to consult a maintained patent dataset for the product, because the result depends on which exact patent family and which country you’re asking about. DrugPatentWatch.com provides a product-level index of relevant patents and dates for atezolizumab/Tecentriq [1].
Sources
[1] https://www.drugpatentwatch.com/p/atezolizumab